SichuanKelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”, 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Lung05) of the company's TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870), in combinationwith MSD's anti-PD-1 therapy KEYTRUDA®[1] (pembrolizumab), as a first-line treatment for PD-L1-positive advanced non-small cell lung cancer (NSCLC), […]

As winter approaches, staying active can become a major challenge. Cold weather, shorter daylight hours, and busy schedules often make outdoor workouts inconvenient or even impossible. For fitness enthusiasts, athletes, or anyone looking to maintain a healthy lifestyle, having a reliable home workout solution is essential. The YESOUL G1 M PLUS Indoor Bike offers the

Galvanize (“Galvanize”) Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the appointment of Laura Francis to its Board of Directors. An experienced medical technology executive, Francis is Chief Executive Officer and a Board of Directors member of SI-BONE, Inc., a medical device

Leveraging Ken's 26 years of core leadership at Intel and Strategic Taiwan ecosystem alliances, SuperX is set to accelerate its deployment and ecosystem expansion. SuperX AI Technology Limited (NASDAQ: SUPX)(“the Company” or “SuperX”) today announced the appointment of Mr. Ken Lau as the Company's Chief Strategy Officer (CSO) and Executive Director of the Board, concurrently

Purolator expects to process 1.3 million pieces a day until Dec. 24, 2025 From Prince Rupert, B.C., to Whitehorse, Yukon, to Corner Brook, N.L., Purolator couriers have begun criss-crossing the nation as holiday shipping season kicks into high gear this week.Purolator, a leading Canadian integrated freight, package and logistics solutions provider, released its annual peak

(NASDAQ:ATON), New York, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital (Nasdaq: ATON), a specialized digital asset technology company focused on the Telegram ecosystem, today announced that it has submitted a Letter of Intent (LOI) to acquire a 51% controlling interest in Forbes Media Holdings (FMH). The proposed acquisition is part of AlphaTON's broader

Wilmington, DE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Edify Engine, widely recognized as the “WordPress of 3D,” today announced the release of its new Agency & Studio Solutions — a major product expansion built for creative agencies, digital studios, enterprise teams, and large-scale production environments. The offering enables professional teams to design, launch, and manage

(NYSE MKT:CANF),(TASE:CFBI),(TASE:CANF.TA), Namodenoson, a Phase III cancer drug has strong potential in veterinary oncology, a market projected to reach $3.1 billion by 2030 Piclidenoson is currently in development for the treatment of osteoarthritis in pets; Clinical studies show efficacy in dogs, representing a $3 billion market RAMAT GAN, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) —

Pune, India, Nov. 24, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading CNAPP vendors. Upwind, with its comprehensive CNAPP solution, has received strong ratings across technology excellence and customer impact. QKS Group announced today that it has named Upwind as a leader in the SPARK Matrix(TM):

(NASDAQ:KTTA),(NASDAQ:KTTAW), — Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – –Cohort 7 Pharmacokinetic (PK) profile continues to demonstrate dose-proportionality and Cmax/Cmin ratio <2. Achieved exposures (AUC) of 6,690 ng– h/mL – — Pharmacodynamic (PD) data support continuous suppression of MAPK pathway throughout the 24-hour cycle – — Safety Review